Operated by Ieldas Inc. · Independent methodology · Affiliate-supported. Read our ownership & funding disclosure and how every figure is verified.
GLP1ProviderFinderUS price records
HomeCompare › bmiMD vs Elevate Health

Head-to-head · computed 2026-08-11

bmiMD vs Elevate Health

bmiMD: bmiMD is a compounded GLP-1 telehealth platform notable for flat per-dose pricing — the rate stays the same whether you're at 2.5 mg or 15 mg — and one of the widest plan-tier menus in the market. Its $99/mo semaglutide and $139/mo tirzepatide on the twelve-month plan are the lowest annualized figures in the dataset for both molecules. Elevate Health: Elevate Health sells compounded tirzepatide at $449 a month on its monthly plan or $263 a month on a prepaid 12-week program, with free blood work included and brand-name Zepbound also on the menu; its compounded semaglutide pricing spans a promotional band our desk has not resolved to a rankable maintenance figure.

Tirzepatide

bmiMDElevate Health
All-in maintenance$179/mo$449/mo
Best plan rate$139/mo$263/mo
12-month total$1,668$5,388
StatusReported · 2026-07-14Reported · 2026-08-11

The arithmetic

On the figures our desk holds, bmiMD's $179 a month undercuts Elevate Health's $449 by $270 a month at the 10 mg/wk maintenance basis — $3,240 across a year. bmiMD's figure is reported (captured 2026-07-14) and Elevate Health's is reported (captured 2026-08-11); a status below 'verified' means our independent checkout capture is still pending, so treat the gap as the best current evidence rather than settled fact.

bmiMD's tirzepatide ladder runs $179 a month billed monthly, $159 a month on a three-month plan, $149 a month on a six-month plan, and $139 a month on a twelve-month plan. Elevate Health's runs $449 a month billed monthly, and $263 a month on a three-month plan. On the twelve-month basis bmiMD's $1,668 beats Elevate Health's $5,388 by $3,720 — with the winner's figure resting on a committed twelve-month plan, a structural difference that matters if you might stop early.

Semaglutide

bmiMDElevate Health
All-in maintenance$129/monot published
Best plan rate$99/mo
12-month total$1,188
StatusReported · 2026-07-14Reported · 2026-08-11

The arithmetic

Elevate Health does not publish a rankable maintenance-dose figure for semaglutide, so no winner can honestly be declared — a start-only price tells you what month one costs, not what the program costs.

Where the structures genuinely differ

On dose economics, bmiMD is dose-flat — the price survives titration — while Elevate Health's pricing can move with the dose, a difference that compounds through a standard escalation schedule and matters most to buyers expecting to reach the higher maintenance doses. On verifiability, bmiMD names its dispensing pharmacy — which means the fifteen-minute license-and-records check is possible — while Elevate Health's pharmacy is not disclosed on record, the single structural fact this desk weighs heaviest after the FDA's 2026 letters cited exactly that practice. On exit terms, bmiMD's structure avoids prepaid lock-in while Elevate Health's better rates ride prepaid terms — cheaper per month, costlier to leave early; read the refund language before choosing the discount.

Structure, side by side

bmiMD

  • MembershipNone
  • Dose policyFlat — same price at every dose, across all plan lengths
  • CommitmentMonthly, 3-month, 6-month, or 12-month plans; price varies by term, not by dose
  • CancellationPer provider terms; confirm cancellation policy at enrollment
  • PharmacyNamed 503A pharmacy partner (specific pharmacy not publicly identified on pricin

Elevate Health

  • MembershipNone
  • Dose policyNot stated on captured materials
  • CommitmentMonthly, or 12-week prepaid program
  • CancellationPer published terms; 12-week program is prepaid — confirm refund terms at checkout
  • PharmacyPartner pharmacy (unnamed on captured materials); clinical network via MDIntegra

What our desk is watching on each

bmiMD: bmiMD's 12-month semaglutide plan at $99/mo is the lowest annualized sema figure in our dataset, beating NexLife's $119/mo and Oak's $133 m2m. Month-to-month sema at $129 also beats Oak's $133, making bmiMD the new m2m sema leader. Tirzepatide 12-month at $139 ties NexLife. Figures are reported status from RangeYourself's July 2026 first-party captures; our independent checkout is pending.

Elevate Health: Captures are dated (tirzepatide plan structure from a September 2025 consumer walkthrough; injectable band $233–$263 from January 2026 materials) — re-capture flagged. Three structural notes: checkout precedes medical qualification in the published flow (BMI ≥30, or ≥27 with a condition, gates approval after payment); the dispensing pharmacy is unnamed on captured materials, which fails this desk's verification workflow until answered; and the platform sells peptide add-ons (NAD+, glutathione) alongside GLP-1s — read the verification masterclass's add-on cautions before bundling. Not on the FDA's September 2025 warning-letter list per directory review; Trustpilot rating carries a review-solicitation flag.

Questions people ask

Is bmiMD or Elevate Health cheaper in 2026?

The tirzepatide and semaglutide verdict blocks above give the computed answer at the maintenance basis, with the verification status of each figure; the short version is that whichever program's all-in monthly number is lower on this page is cheaper on the evidence we hold today, and both rows carry capture dates so you can judge freshness.

What does bmiMD vs Elevate Health miss that checkout will show?

Taxes, state availability, current promotions, and any dose surcharge introduced after our capture date. Screenshot the order summary before paying — that capture, not any comparison page, is your contract.

Why do you compare at the maintenance dose instead of the starting dose?

Because starter pricing lasts one or two months and maintenance pricing lasts the rest of the year; comparing starts against maintenances is the single most common way GLP-1 comparisons mislead.

What do bmiMD and Elevate Health cost over a full year of tirzepatide?

On the plans our database holds, a year of tirzepatide runs $1,668 at bmiMD and $5,388 at Elevate Health — computed from each program's best published twelve-month route, with promotional figures labeled in the sections above and every number carrying its capture date.

Both records live in the normalized database; re-run the math yourself from the downloads. Full record pages: bmiMD · Elevate Health. Official sites: bmiMD ↗ · Elevate Health ↗. Nothing here is medical advice.